These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25617058)

  • 1. [Measurement of d-dimers in non-valvular atrial fibrillation. First prospective Tunisian study].
    El Borgi W; Romdhane S; Sdiri W; Longo S; Hafsia R; Boujnah MR
    Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):279-84. PubMed ID: 25617058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
    Wieloch M; Själander A; Frykman V; Rosenqvist M; Eriksson N; Svensson PJ
    Eur Heart J; 2011 Sep; 32(18):2282-9. PubMed ID: 21616951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.
    Habara S; Dote K; Kato M; Sasaki S; Goto K; Takemoto H; Hasegawa D; Matsuda O
    Eur Heart J; 2007 Sep; 28(18):2217-22. PubMed ID: 17716991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
    Sadanaga T; Sadanaga M; Ogawa S
    J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, anticoagulant treatment and risk of thromboembolism in patients with valvular atrial fibrillation: Results from Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER).
    Kaya H; Ertaş F; Kaya Z; Kahya Eren N; Yüksel M; Köroğlu B; Köse N; Yıldız A; Cimen T; Ulgen MS
    Cardiol J; 2014; 21(2):158-62. PubMed ID: 23799558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
    Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
    Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation control quality affects the D-dimer levels of atrial fibrillation patients.
    Nakatani Y; Mizumaki K; Nishida K; Hirai T; Sakabe M; Oda Y; Joho S; Fujiki A; Nozawa T; Inoue H
    Circ J; 2012; 76(2):317-21. PubMed ID: 22185714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
    Volterrani M; Iellamo F; Rosano G; Guarini P; Pusineri E; Bonassi S; Chimini C; Zaccà F; Proto C;
    Int J Cardiol; 2013 Oct; 168(5):4729-33. PubMed ID: 23948115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy.
    Sadanaga T; Kohsaka S; Ogawa S
    Cardiology; 2010; 117(1):31-6. PubMed ID: 20881392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
    Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
    Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.